Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-2072
    Keywords: Apomorphine ; Butyrophenones ; Dopamine receptors ; Duration of drug action ; Droperidol ; Haloperidol ; Neuroleptics ; Stereotypy
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Rats were treated once with doses of haloperidol or of droperidol below and above the acute ID50 vs the dopamine agonist apomorphine; they were later challenged with an acute dose of apomorphine (0.3mg/kg, SC) and rated for stereotyped behavioral responses. The two neuroleptics were similar in acute anti-apomorphine potency (ID50=0.12 and 0.18mg/kg for haloperidol and droperidol, respectively). The antidopaminergic effects of droperidol persisted for nearly 1 week and those of haloperidol lasted for 20–40 days, depending on the dose given. The computed half-time of disappearance of their antidopaminergic effects was 7.6±1.0 days and 0.59±0.17 days for haloperidol and droperidol, respectively, following a dose of 0.3 mg/kg, and these indices of duration of action did not vary significantly at doses between 0.1 and 1.0mg/kg. Haloperidol reduced the acute entry of 3H-apomorphine into brain by 21.5% 1 week later. Treatment with apomorphine alone just prior to haloperidol (both at 0.3 mg/kg) prevented the prolonged antidopaminergic effects of the neuroleptic evaluated 1 week later. These results indicate that some neuroleptics may have very prolonged activity or retention in tissue at sites of action, even after moderate, single doses. Caution is recommended in the interpretation of studies which assume “neuroleptic-free” conditions of subjects previously exposed to a neuroleptic agent.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Psychopharmacology 48 (1976), S. 91-95 
    ISSN: 1432-2072
    Keywords: Apomorphine ; p-Chlorophenylalanine ; Dopamine ; Serotonin ; Stereotyped behavior
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract The stereotyped behavioral syndrome induced in the rat by apomorphine was enhanced by acute systemic administration of PCPA. This effect was dependent on the dose of PCPA and half-maximal at approximately 150 mg/kg, i.p.; it occurred within 30 min, was greatest between 1 and 5 h and had nearly disappeared by 24 h after an acute dose of PCPA. A similar effect was not found at 24 or 48 h following 3 repeated doses of PCPA of 300 mg/kg/day. This effect of PCPA was not reversed by 5-HTP or by high doses of a decarboxylase inhibitor. PCPA alone did not produce stereotyped behavior, although it produced some behavioral excitation in high doses following inhibition of monoamine oxidase. This acute behavioral effect of PCPA to potentiate apomorphine-induced stereotyped responses is unexplained. It does not seem to be due to depletion of 5-HT or to the formation of an amine as an active metabolite. We suggest that PCPA can have behavioral excitatory actions independent of its 5-HT-depleting action.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-2072
    Keywords: Adenylate cyclase ; Apomorphine ; Apomorphine esters ; Dopamine ; Mouse ; Pharmacokinetics ; Stereotyped behavior
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Stereotyped climbing and clinging responses of the mouse to apomorphine or its ester prodrug, O,O′-diisobutyrylapomorphine were evaluated. Acute doses of the ester up to 0.3 mmoles/kg were tolerated without apparent ill effects. Both aporphines produced dose-dependent behavioral responses that were blocked by neuroleptics. The duration of action of the ester was much greater than that of apomorphine. When maximal initial behavior during the first hour was evaluated, low equimolar doses of apomorphine and the ester were similar in potency; in contrast, the total behavioral response to larger doses of the ester was greater than to apomorphine, evidently reflecting the greater duration of action of the ester. Behavioral responses to both agents during the first hour decreased at doses above 0.1 mmoles/kg. Oxidized or O-methylated apomorphine did not antagonize the behavioral effects of apomorphine. Systemic injection of apomorphine or diisobutyrylapomorphine led to detectable levels of free apomorphine as estimated by a sensitive and selective fluorimetric assay. The time-course and magnitude of the behavioral effects of both agents corresponded closely with brain levels of apomorphine. Apomorphine and dopamine (but not diisobutyrylapomorphine) stimulated adenylate cyclase activity in mouse striatal homogenates—an effect antagonized by neuroleptic drugs but not propranolol. Apomorphine exerted a biphasic effect on the cyclase in vitro and increased cyclic AMP levels in the striatum in vivo. The prolonged activity of apomorphine esters as depot prodrug agonists of putative dopaminergic mechanisms in the brain may provide clinically desirable characteristics.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...